This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Fried, D. W Articles by Mohamed, H. Search for Related Content PubMed Articles by Fried, D. W Articles by Mohamed, H. Social Bookmarking                         What's this?

Proportioned blood cardioplegia delivery systems- are you del iveri ng the [K+] you expect?

Albert Einstein Medical Center, Philadelphia

Hasratt Mohamed

Albert Einstein Medical Center, Philadelphia

This study was conducted to compare the actual potassium concentration [K+] delivered from a standard 4:1 ratio blood cardioplegia solution with the predicted [K+]. We found that the delivered [K+] ranged from 18.15 to 21.2 mEq/I although we predicted 22.0 mEq/I from our mathematical model. The factors that contributed to this difference were investigated. The ratio of blood:crystalloid was determined by: (1) potassium dilution technique; (2) volume output technique; and (3) from the manufacturer's tubing specifications and tolerances. This resulted in blood:crystalloid ratios of 3.86:1 (3.35-4.49:1), 3.74:1, and 4.0:1 (3.47-4.68:1), respectively. Analysis of the crystalloid component revealed an average [K+] of 75.7 mEq/I (70.0-81.5 mEq/I). Patient [K+] during the study ranged from 4.3 to 6.4 mEq/l. When the effect of clinical extremes in ratio, crystalloid [K+], and patient [K+] were considered, a range of cardioplegia [K+] of 16.0-24.3 mEq/I would be predicted. It was concluded that the ability to control the delivered [K+] with any precision is limited. Manufacturers should (1) match the tubing in such a way as to minimize ratio extremes and (2) adopt a tubing tolerance of ± 0.003 inches. Perfusionists should (1) analyse the crystalloid solution prior to cardiopulmonary bypass (CPB) and (2) analyse the cardioplegia [K+] when there is difficulty arresting the heart or if the patient [K+] is excessively elevated.

Perfusion, Vol. 8, No. 5, 401-407 (1993)
DOI: 10.1177/026765919300800507


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?